Loading company…
San Diego biotech building 3D human tissue models, including a liver model for fatty liver disease, for drug development.
Founded in 2017 and headquartered in San Diego, US, Viscient Bio Inc. develops 3D human tissue models, including a liver model that represents fatty liver disease, for pharmaceutical companies and research institutions. The models are positioned as an alternative to animal testing for drug development. Keith Murphy is CEO, and Jeffrey Miner co-founded the company. In June 2019 it raised an undisclosed amount in Series A funding from Methuselah Fund and Thynk Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in